LifeSpan Vision Ventures logo

LifeSpan Vision Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

6

Common Fundraising Type

Equity

Immunis logo
Immunis

Biotech

Remiges Ventures logo
LifeSpan Vision Ventures logo
JLS Fund logo
Continuum Health Ventures logo
BOLD Capital Partners logo

Immunis, Inc. is a biotech company developing stem cell-derived biologics to treat age-related muscle atrophy and metabolic dysfunction.

Series A
$25M
01/11/2025
Article
Integrated Biosciences logo
Integrated Biosciences

Synthetic biology

Integrated Biosciences uses synthetic biology and machine learning to develop therapeutics for age-related diseases.

Seed
$17.2M
10/03/2024
Article
Remedium Bio logo
Remedium Bio

Gene therapy

LifeSpan Vision Ventures logo

Remedium Bio is a biotechnology company specializing in gene therapy, developing an adjustable-dose GLP-1 receptor agonist for superior weight loss and glycemic control as a safer, cost-effective alternative to traditional treatments.

Equity
Undisclosed
09/10/2024
Article
NaNotics logo
NaNotics

Biopharmaceutical

LifeSpan Vision Ventures logo

NaNotics LLC is a preclinical-stage biopharmaceutical company developing NaNots™, novel subtractive nanoparticles that treat disease by capturing and clearing pathogenic molecules from blood, with a focus on oncology and inflammatory markers associated with multiple diseases.

Equity
Undisclosed
10/30/2023
Article
Matter Bio logo
Matter Bio

Genome integrity

LifeSpan Vision Ventures logo

Matter Bio is a longevity holding company that aims to preserve genome integrity and reverse DNA damage through scientific breakthroughs and clinical trials.

Equity
Undisclosed
10/23/2023
Article
Rejuvenation Technologies logo
Rejuvenation Technologies

Longevity Biotech

LifeSpan Vision Ventures logo

Rejuvenation Technologies is a biotech company that uses lipid nanoparticles to deliver telomerase mRNA, with the goal of restoring telomere length and tissue regenerative capacity.

Equity
Undisclosed
10/13/2023
Article